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In February 2004, Korean scientists made the startling announcement that they 
had cloned an embryo and collected embryonic stem (ES) cells. Consequently, 
American scientists have clamored for increased funding from the federal government, 
and claim that the United States no longer leads the world in biotechnology. 
Ilnf'ortunately for these scientists. Americans have had an uneasy past with the idea ol 
ES cells. Since their isolation in 1998, FS cells have become one of the most hotly 
debated ethical issues in this country, and as stem cells become a more politicized issue 
the public's knowledge of the subject will prove increasingly important. As such, this 
paper will lool' at how major media sources such as The iVew York Times. The 
~'athingron Post, Time Maga=inc, and A'etvsu eek among others have presented 
information on stern cells since they first mentioned stem cells in the early 1980s. By 
evaluating hov the media has portrayed medical, ethical, and political aspects of the 
debate, this paper v ill reveal what information has impacted the American public's 
understanding of the issues. Within the stem cell debate, two things have become 
readily clear. The first is that both sides of the debate have strongly held beliefs, hopes, 
and expectations for the course of progress. The second is that the popular perception 
will play an extensive role in determining this course. As such, researching how the 
press and other poplar sources of information have presented the issues of both 
embryonic and adult stem cell research will prove important to understanding where 
both the debate and its advances in biotechnology will take us in the next decades, 
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INTRODUCTION: SHEEP AND STEM CELLS 
When Dolly the sheep bounded into the public light in 1997, she became, besides 
an instant celebrity, the reification of a long and increasingly complex and public 
iscussion involving science, technology, religion, ethics, and politics. During her 
lifetime, from 1996 to early 2003, Dolly and the rest of the world saw the culmination of 
decades of research, debate, and work on three of the most important areas of modern 
science: genetics, cloning, and stem cells. During the 1990s, scientists in the United 
States and United Kingdom led the drive to produce increased research funding from 
both the public and private sectors. Many of these scientists and lay persons alike 
believed that looming breakthroughs in these areas tvould soon revolutionize the way 
that doctors treated everything from simple illnesses to complex genetic disorders. 
While most researchers recognized that treatments remained at least a decade or two in 
the future, their exuberance at thc possibilities quickly and thoroughly sccped into the 
public realm. 
Shortly. after Dolly's appearance in 1997, a team at the University of Wisconsin- 
Madison led by James Thomson announced in their November 199g Science article the 
successful derivation of stem cell lines from a human embryo. While rcportcrs and 1 
politicians struggled to figure out both the details and implications ol this event, 
scientists rejoiced at onc of the crowning moments of embryological research. Ahnost a 
theoretical entity until the mid 1990s, embryonic stem cells and their ability to become 
This thesis 1'ollows the style and format of Isis. 
' Thomson. James A. "Hmhryonie Stem Cell Lines Derived from Human Blastocysts, ' Science, htov. 
1998, 282. 3391: 1145-47. 
any type of body tissue promised new treatments for a number of degenerative diseases. 
To date, early 2004, neither the United States nor the world has witnessed any 
extraordinary leaps or mainstream treatment options using stem cells. While researchers 
have made significant progress with laboratory accomplishments such as the creation of 
pancreatic cells in Petri dishes capable of producing insulin, they have had difficulty 
translating these successes into publicly concrete and evident progress. Today, research 
and testing proceed with increased efforts but with notably fewer hurrahs from the public 
than in the last decade. 
As with cloning, embryonic stem cell research has prompted both ethical and 
political debate since its initial slages of research. Because embryonic stem cell research 
requires the destruction of a human embryo to culture the cells, proponents and 
opponents typically arise based on the pro-life/pro-choice debate. A large percentage of 
scientists and the supporters of choice argue that stem cell research should proceed for 
the sake of the aforementioned progress in medical treatment. Those against abortion 
argue Ihat human life begins at conception and therefore deserves protection under the 
lav . As in most debates, the popular press has provided a basis for a lay understanding 
of the present status and potential of embryonic stem cells. Articles in major newspapers 
and magazines, as v el 1 as other popular news sources such as television and the intcrnct, 
have covered the issue from political, ethical, and clinical points of view. These sources 
have editorialized stem cells' expected and realized medical impact, debated their ethical 
aspects, and observed their ramilications within United States polil. ics. 
Consequently, these popular news outlets have indubitably made a significant 
impact on how people view the important issues within the stem cell debate. The 
authors of these popular articles have had a difficult burden in explaining and arguing 
about a topic of which most of the population has a relatively cloudy understanding. 
Widely read scientific journals such as the United States' Science and the United 
Kingdom's Nature publish some new stem cell development almost monthly, but most 
of it remains beyond the understanding and concern of the public. The stem cell debate, 
however, has clearly become one that the United States' public will at the least heavily 
influence. The failed attempts by the United States Congress to create legislature in 
2001 and 2003 that would ban cloning and related research highlights the political and 
public nature thc debate has already taken. Educating the public on the current and 
future aspects ol'stem cell research and its medical applications has thus become an 
extremely important role for popular news sources. 
As such, this paper will discuss stem cells and the debate surrounding them in 
three ways. I'irst, in order to make this paper readable by a member of any discipline, it 
explains the current science and debate surrounding stem cells. Second, it discusses the 
advances in embryology and genetics since thc nineteenth century that have led to 
current science. Third. and most importantly, it observes and comments on how the 
major news resources such as The New York Time&, The 8'ashingron Post, Time 
Mugazine, and ivewsweek. 
, among others, have presented information on stem cells in the 
three areas most important to popular culture: ethics. politics, and medical rcscarch. 
While some may claim that these news sources have a prc-existing bias, examining how 
they have reported these topics is important because they lead the news in both amount 
of coverage and readership numbers. Regardless of their bias, these newspapers and 
magazines have had an indelible effect on other news sources' reporting and the 
American public's view of stem cells. Using these print news publications from the past 
several years, this paper evaluates the current popular understanding of stem cell 
research and how that understanding has evolved. 
In February 2004, South Korean scientists announced that they had used DNA 
from an adult female to create stem cells genetically identical to the donor. Among 
other reactions, this announcement sparked various editorials announcing the need for 
the United States to increase its stem cell research and resume its place as the preeminent 
research location in the v, orld. Only a week later, New Jcrscy announced its intentions 
to become the second state, behind California. to fund research on stem cells. Despite its 
current stalls, stem cell research's second rise in the United States appears fast 
approaching, and in order to comprehend its ramifications in the near future the United 
States' public needs to look back to understand its past. Given the increasing importance 
of thc stem cell debate within this country, this paper argues that benelicial progress in 
stem cell research and treatment will require increased flexibility and patience from 
scientists, politicians, and the public. 
STEM CELLS AND EMBRYOS 
What is a Stem Cell? 
As biologists Daniel Marshak, David Gottlieb, and Richard Gardner note in the 
introduction to their collection of essays, "Stem Cell Biology, " "there is still no 
universally acceptable definition of the term stem cell, despite a growing common 
understanding of the circumstance in which it should be used. " Although the authors 
then continue to belabor the inexactness of the term, an explanation of the "common 
understanding of the circumstance in which it should be used" should suffice for 
purposes here. uman physiology contains two major types of stem cells: adult stem 
cells (AS cells) and embryonic stem cells (ES cells). Adult stem cells, the more 
developed of the two, exist in any person or fetus after the earliest stages of development 
and remain functioning until death. AS cells give risc to cells that thc body uses up or 
sheds. For instance, the dead skin cells that a person sloughs regularly originate from 
skin cell producing stem cells bcncath the lower skin layers. Likewise, red blood cells, 
the blood cells used to carry oxygen throughout the body, originate from blood cell 
producing stem cells found in the marrow of bones. 
Biologists have understood the value of these AS cells for nearly forty years. 
Until embryonic stem cells gained attention in 1998. AS cells held thc most promise for 
scientists hoping to manipulate and use them to cure various sicknesses. So far, 
treaunents using AS cells have consisted only of restoring blood and assisting in immune 
repair. The most useful and best understood AS cell is the hematopoietic stem cell (HS 
— Vtarsbak, ryaniel R. . et al. , great Cell Birtlrtgv (Cold Spring Harbor, NY: Cold Spring Harbor Laboratory 
Press. 200lk p. I. 
cell). However, research on HS cells, typically taken from bone marrow, suggests they 
may eventually help treat leukemia and lymphoma. As Science magazine writer 
Gretchen Vogel reported in her June 2001 article "Can Adult Stem Cells Suffice?" 
scientists have made gains in utilizing fat cells &om human fat, neuron cells &om 
cadavers, and bone marrow cells &om mice to reproduce tissue types. While the fat and 
neuron cell tests have met with some dispute from within the scientific community, the 
work with bone marrow cells holds a good deal of potential, to the point that 
developmental biologist Douglas Melton of Harvard University claims that "bone 
marrow stem cells can probably form any cell type. " 
While laboratories continue to evaluate the possibilitv of producing advanced 
cell types from marrow stem cells, many scientists have remained ready Io note the 
problems with using AS cells in both research and treatment. First, while AS cells can 
form scvcral types of tissue, what scientists call being multipotent, they cannot fomi all 
types ol' tissue, or be pluripotent. '1'his aspect could al'1'ect finding a cure to major 
problems such as diabetes or Parkinson' s, two diseases suspcctcd to be difl icull to treat 
wnth AS cells. Second, AS cells purportedly lack lhe ability to divide and create lines as 
ES cells can. This fact strictly limits the availability of AS cells, because it requires 
scientists to gather each one directly from a research subject. Third, AS cells have 
undergone standard aging and may have complications resulting from their deteriorated 
genetic information. Onc way to gel. around the aging and availability problems has 
' 
'NIH Back rounder on Stem Cells, " (Bethesda, Mnc National Institutes of Ilealth, 25 Mar. 2003k 
=-'wwia nih. gov/news/hackgrounders/stemcellhackgrounder, htm& 
' Vogel, (Irctchen, "Can Adult Stem Cells Suffice' ?', \'c ience. . luna 2001. 292, 5523: I 820-1822, on p. 
1822 
been to collect AS cells from the umbilical cord blood of newborn babies. This process, 
used since 1988, typically treats people suffering from anemia or other blood disorders 
in which the patient lacks the blood stem cells to produce adequate red blood cells. 
Although scientists have known about AS cells longer than ES cells, they have not yet 
discovered how to use them to treat any diseases other than blood related diseases. A 
common misconception exists that AS cells have already treated more complicated 
diseases in human trials. ' In regard to neatments for diseases such as Parkinson's or 
diabetes, AS and ES cells remain in the same stages of laboratory testing. 
Embryonic stem cells occur in the early stages of embryonic development, only 
'+two to three days, and are typically collected from what embryologists call the blastocyst 
stage of an early fertilized embryo. The egg, fertilized at conception, splits into two and 
then each of the two divide to produce four and so on in an exponential growth pattern 
for several divisions. After splitting cells have divided a few times they reach the 
blastocyst stage which has specialized protective cells on the outside and pkiripotent 
cells on the inside. Scientists pierce the external layer of cells and collect the internal 
stem cells, destroying the embryo. Once they have been removed from the embryo, the 
cells are tvpically placed on a bed of tnouse cells rel'erred to as "feeder cells. " These 
feeder cells send as yct unknown signals to the ES cells that prevent them from dividing 
into more advanced tissue such as ncurons, muscle, and bone. Once the proper 6 
environment exists. ES cells can either remain in stasis or multiply based on lhe slimulus 
' 
"NIH Report Backs Embryonic, Adult Stem Cell Research. " (CNN. corn, 17 July 20011. 
-. www. cnn. corn, '2001/HEAL I H/07, 'I 7/N I H. stem. ce I Is& 
"Scientists Find New Way to Grow Human Emhryonic Stem Cells. " (Baltimore, Mgk Johns Hopkins 
University, 18 Mar. 2003). &www. hopkinsmcdicine. org/press/2003/Marchi030318. htm' 
they receive. This appeals to researchers because in theory it will provide them with 
stem cell lines that can produce a virtually unlimited amount of ES cells with which to 
work. Furthermore, scientists suspect that ES cells have a greater range of possible 
tissues including the heavily sought after pancreatic cells that produce insulin and could 
drastically help neat diabetes. While AS cells can produce many types of tissues, ES 
cells may have the ability to produce an extremely valuable tissue type that AS cells 
cannot. 
Despite their great potential, ES cells have two major difficulties. First, the 
cellular mechanisms that cause ES cells to form tissue cells have eluded the 
understanding of rcscarchers. I lntil scientists have grasped the minute processes that 
cause the stem cells to become a certain tissue they will have a difficult time proving a 
procedure's reliability. Sci'cntists formerly believed that stem cells could be injected into 
any deficient area and the surrounding cells v'ould indicate to the FS cell what kind of 
tissue it needed to become. I'or instance, an FS cell injected near other ncurons v'ould 
form neuronal cells and an FS cell injected into bone marrow would form bone marrow 
cells. Unl'ortunately, growth factors have proven more complicated than this. For 
instance, doctors in China injected ES cells into a Parkinson's patient's brain hoping that 
the stem cells v ould grow into replacement nerve tissue. When the patient. died 
therealler, an autopsy revealed an unexpected grossth of hair, skin, and bone, referred to 
as a teratoma. ' In the I]oiled States, researchers have conducted similar experiments on 
' Krauthammer, Charles, "The Great Siam Cell Hoax, " Th» Jyeetdy Srnndrrrd, August 2001, 006, -'l6. 12- 
13. 
mice with varied results. Sometimes the mice managed to regenerate lost tissues as 
complicated as nerve cord cells and sometimes the tests have had no success whatsoever. 
Second, the aspect around which most of the stem cell debate revolves, the 
creation of ES cells quires the death of the embryo during the cellular harvest. 
Typically the ES cells have been taken from the unused embryos created by fertility 
clinics after in vitro fertilization, but can also be found in embryos aborted between five 
and nine weeks. And now, thanks to the advances in Korea, they can also be recovered 
from embryos of adult clones. As of President Bush's decision in August 2001, 
American scientists working with federal money only have access to sixty-four already 
existing ES cell lines. For now, public funds cannot be used to produce new stem cell 
lines or be used for research on lines developed after August 2001. Some researchers 
have complained that this mandale has considerably limited the availability of stem cells 
and made useful research difficult to accomplish. As a result, they contend, the United 
States has fallen from iis preeminence in thc field ol'FS cell research„Most scientists 
have agreed, and the National Institutes of Health supports, that ideally research in stem 
cells should consist of boih AS and ES cells. 
Cell Growth: Embryos, DNA, and Clones 
During thc late 1990s Ihe world vritnesscd advances in multiple areas of science 
and technology. As satellites beamed information through thc air and microchips and 
the internet turned inlormation into 1 s and Os. biolechnology bloomed. Since its 
beginning in the 1970s biotcchnology had remained a relatively silenl science, but then 
""Information on Eligibility Criteria for Federal I unding of Research on Human Embryonic Stem Cells, " 
(National Institutes of Health, g Mar. 20041. '-stemcella. nih. ov, 'registry'ehgibilityCriteria. aspc 
in the late 1990s two enormous biotech undertakings drew the public's attention. The 
1996 birth of Dolly and the race to map the human genome, all the genetic information 
in a human, brought forth the quiet labors of biotech scientists. These two results along 
with James Thomson's isolation of human ES cells started what many people saw as the 
next medical revolution. Over the past century, biologists had amassed an impressive 
understanding of how the fundamental aspects of life function and felt confident that 
they would soon manage to put their developments into practical use. Therapeutic 
cloning and ES cells, with their ability to morph into any tissue, seemed especially 
exciting. So scientists claimed that in only ten to fifteen years they would have the 
capability to transform embryonic stem cells into one of the most profoundly useful 
medical tools since Scotsman Alexander Fleming's (1881-1955) discovery of penicillin 
to fight bacterial infections in 1928. 
Like Fleming's notion in its time of usin«a substance to fight infectious bacteria, 
the use ol' stem cells or genetic treatment to cure diseases could have hardly been 
understood sixty years earlier. "As a separate discipline, " British anatomist T. J. Horder 
notes in his introduction to A History of Lmbryolo~, "embryology did not exist until 
some time in this century (twentieth). " Fven as late as the 1940s Gra) 's Anatomy had 
only proposed drawings of what the human embryo should look like at iis earliest sta&res. 
Despite this relative lack of knowledge, scientists had bccn looking at organisms' older 
embryos since the late nineteenth century. (lntil then scientists suspected the earliest 
stages o I' the human form to resemble a miniaturized human seen at birih. One of the 
' Horder, Td. A Hrsrorx of ErnhrJ oioxr (Jsiew York: camirridgc iinivcrsiiy Press, 1986), p. 3. 
prevalent notions suggested that conception produced an even more miniaturized human 
form commonly referred to as a homunculus. Another version called epigenesis, 
Aristotelian in nature, claimed that the swelling at pregnancy came from the realization 
of potential created at conception and subsequently guided by a mysterious and 
transcendent vital force' . As with physics in the seventeenth and eighteenth centuries, 
people still sought to understand the life sciences in philosophical rather than 
experimental terms. Even when in 1827 German biologist Karl Ernst von Baer (1792- 
1876) discovered that mammals form eggs, researchers struggled to understand the 
processes taking place within the egg or to provide some conclusive evidence to prove 
any of the prcvalcnt theories. 
)slot until the technological progress in microscopic staining in the mid- 
nineteenth century could biologists study the later stages of the developing human 
embryo. With better observation tools and German biologist Wilhelm His' (1831-1904) 
1880 studies of cross-sectioned fetuses from various stages of dcvclopment, 
understanding in embryology gradually improved. However, despite their advances, 11 
scientists still lacked knowledge of the physiological processes taking place within the 
v, omb. In 1891, hoping to corroborate the notion that a vital force provided the drive, 
German embryologist and philosopher I lans Driesch (1867-1941) separated sea urchin 
cells after their first cellular division. To his excitement, the separated cells grew into 
adults and led Driesch to conclude correctly that after thc first and second cellular 
'" Maienshein. Jane, "What's in a Name: Embryos, Clones, and Stem Cells, " I'he Arrrerrean yournot og 
Broerhies, Winter 2002, 2, t: 12-t9, on p. l2. 
Maienshein, "What's in a Name, ' p. 13. 
divisions the individual embryonic cells' fates had not been fixed. ' Although other 
studies showed both that various organisms' cells had different types of division and 
debunked had Driesch's belief in the vital force, this discovery has since had significant 
impact on the study of human embryology during the twentieth century. 
Although no one could grasp the idea until nearly a century later, Driesch 
produced totipotent cells, those capable of becoming entire living organisms, and the 
rudiments of modem ES cells. Unlike Driesch's totipotent cells, today's pluripotent ES 
cells come from a more developed form of the embryo and cannot become living 
organisms. Nonetheless, Driesch's experiment proved valuable for the understanding ol 
what information exists in carly embryonic cells. However, before researchers could 
theorize on using the plasticity of developing cells, they would spend nearly a century 
investigating the science that causes the cells to grow into the adult lorm. The 
rediscovery in 190tJ of (lregor Mendel's (1822-1884) nineteenth century work on 
characteristic heritability in pea plants quickly created an emphasis on determining the 
complex formative features of biology. Along vvith this, developments in chromosomes, 
the slructures that support the cell's genetic material and cell cycles, gave scientists an 
idea of processes occurring within cells. Then, in 1907, Ross Harrison (1870-1959) 
cultured the first tissues outside ol' lhe body by growing frog nerve tissue on a medium 
of lymph clotting tluid. While not an earth shattering gain, the experiments allowed t3 
him and other researchers to I'urther understand the processes of growing specific tissues 
Bowrintn Finn, "Therapeutic and Reproductive Ctoning. a Critiztue. ", S'nczu/ Xczences and zvrezticine, Jan. 
2004, 58, Z: 401-40tJ. 
'" 
"Harrison, Ross Granville, " Cvlzrzzztzrzz hncvcIzztzeCkzz, 6a ed. , 2004. 
from basic cells. After around 1910, however, studies in embryology decreased as a 
result of the lack of scientists' understanding in embryological physiology. Then, in 
1953, the combined efforts of James Watson (1928- ), Francis Crick (1916- ), Maurice 
Wilkins (1916- ), and Rosalind Franklin (1920-1958) revealed the shape of DNA, and 
presented the possibility of understanding the chemical constructs of life. With these 
developments, scientists began to wonder at the possibility of manipulating human 
genetic information to treat disease and conditions that standard medicines could not 
cure. 
During the 1970s James Watson appeared before Congress to testify on the 
importance and inevitability of researching adult cloning, a thought that some scientists 
at the time dismissed as impossible. His appcarancc belied a new social and political 
concern regarding embryos and the early stages of human grovth and hov' nev' 
technology might impact the future. I cchnology, it seemed, had begun to dangerously 
approach some of the issues that had previously stayed within the realm of science 
fiction v'riting. In the 1950s, Robert IJriggs and Thomas King had successfully injected 
tadpole embryonic cells into evacuated frog eggs and created genetic copies of the 
tadpole donors. With a more accurate understanding of genetics and an improvement 14 
of tcchniqucs, scientists such as Watson argued that transferring complete genetic 
information from an adult into an evacuated egg would become ineviiable. Social and 
political uneasiness increased in 1978 "when Patrick Steptoe's team demonstrated thc 
Bovring. "Thcrapcuuc, " p. 401. 
astonishing efficacy of in vitro fertilization. "' With this advance, scientists could create 
embryos outside of the body. For the most part, the public viewed this advance as 
beneficial because it allowed otherwise sterile parents the opportunity to have babies. 
With the addition of work in genetics, embryology returned as one of the leading 
biological sciences during the 1980s. Using the nuclear transplantation methods devised 
by Briggs and King for tadpoles and frog eggs, scientists began to attempt cloning 
mammals from embryos. During the past several decades, scientists have developed the 
following different techniques to create genetically identical organisms. The first type, 
embryological cloning, occurs after fertilization when the egg receives half of its genetic 
material from each parent. Once the early cells reach the two-cell stage, scientists split 
the cells apart. After splitting they grow into separate genetically identical embryos as in 
the case ol'Driesch s sea urchins. Nature has done this process for millennia in thc form 
of identical twins. The second type, as in the case of Briggs and King*s tadpoles, uses 
embryonic cells that have not undergone as much differentiation as adult cells. During 
the 1980s, scientists made significant advances by cloning animals such as cows and 
sheep from embryos sometimes as old as eight weeks. This science turned to humans 16 
vihen in October 1993 researchers . lerry Hall and Robert Stillman from George 
Washington University divided eight-cell human embryos into single embryonic cells 
and created identical human twins. 17 
Maicnshein. "What's in a Name, " p. 14. 
' Bowring, 'Therapeutic, " p. 401. 
Harris, John, (7unex llenen und Immortuliry Ethics unrl ihe Genetic Rerolnlion 1New York: Oxford 
University Press, 1998)h p. 27. 
The first cloning from an adult cell was of course Dolly's 1996 creation by Ian 
Wilmut and Keith Campbell of the Roslin Institute in Scotland. This third and most 
important type of adult cloning extracted Dolly's aged DNA from a mammary cell and 
inserted it into one of her eggs, from which the nucleus had been removed. This egg 
then underwent cellular division and formed an embryo and fetus like any other 
fertilized egg. Since Dolly, researchers have come to refer to either therapeutic cloning, 
in which a clone is created for the purpose of replacement parts or stem cells, or 
reproductive cloning, in which the clone develops into a normal adult. Both of these 
types of cloning have encountered huge amounts of ethical debate within both scientific 
and political circles. Foremost, opponents of adult human cloning fear that the line 
between the tv o types, therapeutic and reproductive, will prove difficult to define il and 
when human adult cloning becomes more easily facilitated. Opponents, v'ho consist of 
mainstream biotech scientists. cthicists, and religious groups, argue Ihat the creation of 
clones, whether used I'or their genetic material as embryos or aHowed to grov into 
adults. undermines the value of cloncs' lives and in turn the value of human lil'e. Their 
projections of biotech controlled societies reminiscent of the fears of science fiction may 
have some relevancy as some ethicists and scientists have already taken to referring to 
cloncs as cyborgs. As bioeihicist Greg Pence of the University of Alabama at ls 
Birmingham notes. "scicncc fiction movies have iaught us that this technology must 
create mutants, but in fact, any problems we' re facing arc mcrcly tcchnical. And fear of 
" Eox, Vi, "prc-persons, Commodities or Cyborgs; the Legal Construction mid Representation of the 
Embryo, " Hectic Cure. inoiysnn 2000, 8, ih l7I-I88. 
technical problems is just masking other problems people have with the idea of 
cloning. n' 
While these arguments over cloning are not currently at the heart of the debate 
over stem cells, they will soon have greater significance. One of the goals that scientists 
have sought since stem cell treatment began has been to create a clone of an adult and 
then extract genetically identical ES cells. In February, Korean scientists used an adult 
woman's DNA and egg to create a cloned embryo from which they extracted ES cells. 
Many in the field believe that a genetically identical stem cell may prove more capable 
of interacting with the already existing tissues during treatment. Although this type of 
adult cloning is currently possible only with women able to produce eggs, the ethical 
arguments regarding the sanctity of her clone still apply. Internationally, several 
countries have outlawed cloning and lhe United Nations' Ad Iloc Committee on an 
International Convention Against the Reproductive Cloning of Human Beings will likely 
2 
meet for a third time in as many years late in 2004 to discuss the possibility of creating 
an inlernational prohibition on at least reproductive cloning, and perhaps also therapeutic 
cloning as well. 2I 
Although Dolly's cloned status made lhe greatest impact on the public, her 
creators' main focus had been to insert a human gcnc v'ithin her that would produce a 
complex protein. I)ntil then, scientists had to rely on genetically altered bacteria to grow 
w Reeves, Jessica. "Human Cloning: Cause for Reloicin or Despairs" (Time. corn, 9 March 2001). 
&www. time. corn/time/world/article/0. 8599, 101998. 00. htmt& 
Pollack, Andrew, "scientitic and Ethical Questions Cloud Plans to Clone for Therapy, " T/te A'eii Yrirk 
'/)/mein 13 Pch 200m A l. 
"Ad Hoc Committcc on an International Convention Against the Reproductive Cloning of Human 
Beings, '* (United htations. 15 Dec. 2003). swww. un. org, 'law, 'cloningc. 
replacement proteins needed to treat various diseases. By infusing the human gene into 
Dolly, Wilmut and Campbell hoped that Dolly would produce a protein in her mammary 
glands too complex for bacterial cultures. While Wilmut and Campbell's attempt to 
create a hybrid has remained relatively unknown, they did manage to bring together 
genetic manipulation and cloning in mammals. As such, Dolly not only demonstrated 
the possibility of adult cloning, but she also showed geneticists' ability to genetically 
engineer a complex animal. Since then, the notion of gene therapy has taken its own 
course and incurred its own separate debate. Gene therapy applies to the stem cell debate 
in regard to whether and the degree to which mankind should interfere with natural 
processes and random determination. By learning to control the fundiunental clcmcnts 
of life, scientists in this field now have a responsibility to educate the public on the new 
potential within their grasp. As cloning and genetics reached their heyday in the late 
1990s with the aid of computers and other technology, thc debates over ethics and the 
impact on thc value of human life heated up within the scientilic iield, then boiled over 
into the public realm. 
Amidst the notoriety of these other two sciences, embryological stem cell 
research arose during thc 1990s as a relatively quiet step child of cloning. At tirst, 
popular attention overlooked stem cell research for the more glamorous exploits in 
cloning. For instance, '1'homson's isolation of human stem cells a year after Dolly' s 
creation has received notably less public acclaim despite its arguably greater signiticance 
to future medical treatment. Then in 1999 thc scientilic v, orld's and public's attention 
shifted to I'urther understanding the new stem cell technology and its future possibilities. 
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This focus continued for only a few years, however, until President Bush's restrictions of 
ES cell research created what many scientists have referred to as "a brain drain of 
experts, " With more restrictions on United States funding, countries such as Great 
Britain have risen to the top of this area of research. Furthermore, researchers fearing 
further restrictions on stem cells and cloning have increased their cries for more funding 
and access to necessary resources. As in the case in Korea, cloning and ES cells have 
now become closely related. Furthermore, Dolly's euthanasia in 2003 for premature 
aging and arthritis has cast considerable doubt on the viability of reproductive adult 
cloning from aged DNA. As a result of the melee of ethical questions on both cloning 
and stem cell research, American researchers have had to pare back their earlier 
predictions of medical revolutions looming around thc corner. 
Defining the Debate 
The stem cell debate has evolved since ES cells came on the scene in 1998. 
Before November 1998, the public had heard little of stem cells in their morning papers 
and news magazines. As mentioned before, doctors had used AS cells to treat blood 
deficiencies for some time, but none of this had garnered much attention from the public 
interesk Then the publicity explosion over Dolly made a big impact on the attention 
given to biotechnology and genetics. As bio-ethicist Finn Boy ring notes in his article 
"Therapeutic and Reproductive Cloning: a Critique, " 'the arrival of Dolly dispelled tv o 
decades of complacency" among ethicists regarding the possibilities of a biotech 
revolution. While the papers printed headlines such as "Fwe Two, " professional 22 
Bowrin, "Therapeutic. " p. -'102. 
attention turned to the possibilities of therapeutic cloning and the development and 
application of human ES cells. Then Thomson isolated human ES cells, and for the 
general public learned of a new element in the biotech revolution. 
While both of these events stand out, Thomson's isolation posed considerably 
more important ethical questions. Primarily, ES cell isolation had required and would 
require the destruction and manipulation of human embryos rather than sheep or one of 
the other mammals since cloned by scientists at various institutions. Rather than simply 
working on an animal, scientists had used human embryos for research that most 
Americans at the time did not understand. This new and strange process immediately 
infused the debate over cloning and its new technologies with a ncw category of ethical 
concerns. Scientists had knowingly stepped into the fierce debate over the rights of 
fetuses and embryos. The issue initially seems similar to the pro-life/pro-choice debate; 
however, the issue proves more complicated since the stem cells being used typically 
come from excesses embryos crcatcd at in vitro reproductive clinics. Thus the embryo, 
despite its viability, v ill otherwise spend its days frozen in stasis at the clinic. This 
aspect adds a different angle to thc older debate. Proponents of ES cell research claim 
that, since the embryo has no possibility of coming to tenn, it would better serve thc 
world in scientitic study. Opponents remain lirm that something with the potential ol 
human life should enjoy protection under the law alforded to both people and fetuses 
terminated without the consent ol' the mother. 
' Terner, . John R. G, "Ewe Two, " 7'he, yen' J'or/r Tnaein 28 Dec. J 997' Z J. 
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The science and debate regarding stem cells have evolved simultaneously since 
their origins in the late 1990s. Those typically in favor of ES cell research have been 
mainstream scientists and celebrities afflicted by diseases that could ideally be cured by 
advances in stem cells, such as Christopher Reeve and Michael J. Fox. Politically, 
moderate Republicans and the majority of Democrats side in favor of ES cell research. 
Opponents include the Catholic Church, pro-life organizations, a few, typically 
ostracized, scientists, conservative Republicans, and a small number of Democrats. 
Democrats such as Bart Stupak (MI) and Mary Landrieu (LA) have cosponsored bills 
that would strictly limit cloning and stem cell research. Almosl all parties against the 
research claim that AS cells should have the ability to do exactly what an ES cell can 
do. The notion that AS cells will someday suffice for ES cells has recently become the 
most hotly argued aspect of the debate. Many supporters of AS cells, such as the pro- 
life lobby and scientists working with AS cells, claim that mainstream science and 
leading scientific magazines have squelched reports thai reveal the benefit and utility of 
AS cells for fear of losing ES cell rcscarch funding. As the debate over publicity 
continues among scientists and politicians, ES cell research proponents and the National 
Institutes of I lealth maintain that thc inability of AS cells to reproduce in cullure and 
their limiied multipotency niake ES cell research necessary. 
Currently, both types of stem cell and cloning advances v ithin the United States 
have l'ailed to live up to scientists' original hopes and expectations. While this certainly 
comes as a disappointment to many stem cell research supporters. it also provides an 
Prentice, David A, 'Adult Stem Cciia: Draft, " iThe Ritz Carlton, Washington D. Cc Meetmg of The 
President's Council on Bioethics, 23 July 2003). vvtvvv. bioethics. gov'background/prentice paper. html& 
excellent moment for both sides of the stem cell debate to reflect on the advances to date 
and the prospects for future technology. Within the stem cell debate, two things have 
become readily clear. First, both sides have large numbers of supporters. Since the 
debate has its foundations in the pro-life and pro-choice political arguments, it has 
received an influx of energy and emotion from both sides. Furthermore, it brings in the 
ethical arguments that have flooded scientific and technological communities during the 
second half of the twentieth century. How far should science and technology go? What 
are the risks of plodding on in science without oversight and input from ethics-minded 
and non-scientific bodies? Second, as seen in the case of the 2001 and 2003 bills before 
Congress, popular perception of the issues will have a significant impact on the direction 
of the major aspects of stem cell research. While scientists might prefer to work in the 
relative anonymity they had during the carly 1990s, they have crossed definitively into 
the public and political realms. Because cures and treatment options remain distant, 
biotechnologists have had difficulty generating private sector I'unding for stem cell 
research. Until February, no state had set grant money aside for ES cell research, and 
Nev, Jersey's proposed six million dollars remains small in an industry as vast as 
biotechnology. If measurable progress occurs, it v;ill almost certainly require funding 
provided by the federal government. I'or an increasingly important topic such as stem 
cells. public opinion will play a significant role in how this funding is allotted. As such. 
researching how the press and other poplar sources of information have presented the 
issues of both embryonic and adult stem cell rcscarch will prove important to 
understanding where the dcbatc and science v ill take us in the next dccadcs. 
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STEM CELLS IN THE PRESS 
In November 1998 news sources across the country ecstatically heralded the 
isolation of an extremely important part of modem biological science. These news 
articles assured readers that scientists were extremely excited that these new embryonic 
stem cells would eventually allow doctors to produce new types of tissues "including 
bone marrow for cancer patients, neurons for people with Alzheimer's disease, and 
pancreatic cells for people with diabetes. " ' Clearly, scientists had been expecting this 
development and pondering its potential ramifications for quite a while. Furthermore, 
reporters added, the new discovery came complete with already existing debate about 
whether this new technology would alter the value of the embryo. The language of the 
reports made the isolation of embryonic stem cells seem like the inevitable and expected 
next step in biolechnology. But what had these same news sources printed about thc 
inevitability of hutnan embryonic stem cell isolation before November 1998? In the 
fifteen years prior, The iVew York I'i mes used lhe phrase "embryonic stem ccII" only 
twice in science and technology reports in August 1996 and November 1989 and once in 
an editorial in February 1998. The IVashington Post had slightly morc to say on tbe 
topic with six reports between April 1990 and October 1997. The only 1998 mention of 
embryonic stem cells before November had occurred in a single The 2Veiv York Times 
article in February aboul lhe senate's attempt to create a cloning ban. Despite 26 
reporters' claims of apparent inevitability, Thomson s discovery had taken major news 
sources by surprise. This may explain why nev spapers since then have taken embryonic 
' Weiss, Rick. "A Crucial Human Cell ls Isolated, Multiplied, " The ltharhtngtort Posh 6 Nov. 1998: A 1 
Wade, Nicbolaa "Senate Plans to Weigh Ban on Clonin, " The Vetu Fork Tones. 19 Feb. 1998: A l. 
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stem cells more seriously. Between November 1998 and March 2004, IYasltington Post 
writers used the phrase "embryonic stem cells" two hundred and forty three times. The 
New York Times, not to be outdone again, used the phrase fom hundred and fifteen 
times. 27 
Stem Cell Isolation: 1980-1989 
While embryonic stem cells may have taken these newspapers by surprise, adult 
stem cells, formerly just "stem cells, " received a generous amount of attention. The New 
York Times first referred to stem cells in story on David the 'bubble boy. *' The October 
1983 article states that after David received a bone marrow transplant from his sister, 
doctors hoped the remaining 'embryonic bodies known as stem cells" would hopefully 
'adapt themselves into cells compatible with David's body as they grow to maturity. " 28 
At the time, scientists used the designation "embryonic" to refer to any type ol' stem cell 
because they gave rise to other cells. As such, the article refers not to embryonic stem 
cells but the AS cells within the sister's bone marrow. Thc term stem cell ltrst appeared 
in The /Voshington Post in October 1985 in the article "Righting Nature's Wrongs; Ocnc 
Therapy On the '1'hrcshold of Medicine's Next Revolution. " fhc article mentions only 
that stem cells have something to do v ith bone marrow, and that geneticists hoped to usc 
them as transports of genetic therapy. ln reality. scientists sought to genetically alter 
"7 1'hcsc numbers were obtained bv searching thc Lexis Nexis Academic database for the words in 
parentheses. Aside from the embryological term, "stem cell" can be used with botany. I lowever, the 
numbers of articles with botanical references were approximately two or three out of one hundred and 
would make no significant difference in thc linal numerical results. In results with numbers below filly, 
the botanical references were excluded. 
""3-Month Wait Seen I' or Boy in Bubble, " The A'ew York Times. 28 October l983: A4. 
Squires. Sally, "Righting Nature's Wrongs; O&ene Therapy On the Threshold of Medicine's Next 
Revolution, " The li&uhingir&n Pr&ti, 30 Oct. 198S: A I 0. 
bone marrow stem cells and then use the altered cells to repopulate the system. 
Although AS cells proved difficult to isolate and alter, scientists continued to mix AS 
cells and gene therapy for the next decade. Both of these articles provided little or no 
scientific explanation or further information on stem cells, One possible explanation for 
this lack of information is that the scientific community did not fully comprehend adult 
stem cells and could only theorize on embryonic stem cells. These two articles also 
show that, despite their incomplete understanding, scientists understood the potential of 
modifying AS cells to produce deficient or altered cells. None of the stories from the 
early 1980s discussed ethical or political issues directly related to stem cells. However, 
several stories did mention ethical concerns regarding genetic engineering and asked the 
question that will dominate the biolech industry for the next two dccadcs, "just because 
science can do something, does it mean that it should' ?" 
tVewstveek's early stories included better explanation of thc scientific facls. Ils 
first article in February 1983 entitled "Beefing l?p the Bone Marrow, " noted specifically 
that marrow stem cells give rise to both white and red blood cells. The article stated 30 
that scienlisls at New York's Memorial Sloan-Kettering Cancer Center had discovered a 
means to disarm the white blood cells that interfere with tissue-immune acceplance. At 
the time, scientists hoped that this important achievement would allow for bone marrov, 
transfusions from donors with inexact marrow matches. While this science never fully 
blossomed, a result of scientific complications in removing the white blood cells, it 
brought stem cells into the popular vernacular and encouraged scienlisls to pursue the 
' Clark, Matt with John Taylor, "Beefing tJp thc Bone Marrow, " JVenrneeek. 18 Feb. l983. 102, ': 75. 
idea of using stem cells to replace defective tissues or chemicals. Four more stories in 
Newsweek followed this initial use until 1986 when no articles mentioned stem cells 
until 1993. These four stories all concentrated on developments within the transplant 
sciences and discussed how bone marrow transfers could treat leukemia and childhood 
immunodeficiency diseases. As in newspaper articles of the time, none of these 
magazine stories mention political issues or ethical considerations surrounding stem 
cells. However, while it may have remained almost a decade away, some reporters did 
begin hint at the possibility of cloning sciences and complicated genetic therapy. 
For the next decade and a half, ideas on using extracted or modified AS cells to 
treat disease grew and spread among the medical field. While neither scientists nor lay 
people knew precisely the final destination of thc combined el'fects of all of this new 
technology, they both understood that bigger developments rested on thc horizon. 
Before these new developments arrived, however, AS cells would become suspect for 
the cause of cancers that come about as thc result ol'certain AS cells' improper 
divisions. Fortunately for stem cells, this negative attention spanned a brief time 
between 1985 and 1986. I lope for treatments of diseases with stem cells began in the 
late 1980s when reports of results on lab mice and other animals became increasingly 
prominent. In July 1988, The IVathinglvn Post reported that Stanford I!niversily 
Medical School researcher Irving Wcissmanbone bad isolated and grov;n mouse bone 
marrow stem cells in his lab. The story went on to note that having succeeded in sl 
isolating mouse stem cells, scientists planned to begin attempts to isolate human AS 
Hilts, Philip . I, 'Stem Cells Grown in Lab, " 1'he hvorlrinpron Posr, I I July I 988: A3. 
cells. A month later The New York Times covered this exciting new topic with an 
examination of the potential of isolating these bone marrow stem cells. Harold M. 
Schmeck's article, exuberantly titled "'Holy Grail' of Blood Research Is in Sight, " was 
one of the most important stem cell articles of the late 1980s. The article not only 
notes the suspected success of attempts to isolate human bone marrow stem cells, but 
also examines the medical benefits of their pure isolation. While Schmeck focused 
mostly on advances with bone marrow treatments, he also noted that scientists still 
lacked a complete understanding of AS cells. Although mainsu earn science had not yet 
realized AS cells' full potential, this moment presents the first major attempts to 
specifically isolate human stem cells for treatment. 
Throughout the 1980s, AS cells evolved from un-isolatablc cells within the bone 
marrow to internationally pursued subjects of medical iuiticipation. The isolation and 
assay methods developed during this Lime would establish the foundations for future 
tvork with AS cells. Although neither scientists nor lay people realized the value beyond 
red blood cell regeneration, they began Lo 1'ormulate ideas about how these basic cells 
could replenish depleted or malignant cell populations. As scientists made advances in 
cell biology and gene therapy, bioeihical consideraiions played an increasingly 
significant role with research and development of new procedures. Many research 
institutions created in-house bioethics panels, and the position of the bioethicist began. 
During much of the 1980s, bone marrow stem cells did not receive much attention from 
early bioethical or political discussions because they came from adult bone marrow 
Schmeck, I Iarold M. "'I loly Grail' of Blood itesearch Is in Sight, " The Ãmr York Times, 23 Aog. 19gII: 
CI. 
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donations, a donation process slightly more invasive than giving blood. As a result, 
scientists and doctors working with stem cells had relative freedom in how they 
conducted their research. 
This freedom ended in 1989 when some scientists introduced bone marrow stem 
cells into the ongoing debate over transplanting aborted fetal tissue. In his February 
1989 5'asltington Post article, "ETHICS: How Abortion Politics Stifles Science, " John 
C. Fletcher claimed that current National Institutes of Health restrictions preventing the 
use of fetal tissue in research had encumbered drastic gains in both research and 
treatment options. He supported using both the bone marrow stem cells from aborted 33 
fetuses and the extra embryos created by in vitro fertilization. Again, the stem cells he 
spoke of were not embryonic stem cells in the modern sense, but AS cells taken from the 
bones of late stage fetuses. In this case, the tissues came from fetuses or embryos thai. 
people had already aborted, but opponents argued that scientists should not violate the 
sanctity of the fetus by scrapping it for spare parts. Despite Fletcher's title "ETHICS, " 
his only ethical contention is based on the simple but compelling argument: "v'hy not 
utilize what already exists. ' In his statcmcnt, "obviously, scientists should not be 
permitted to do anything to a pre-embryo or fetus at any stage, " Fletcher revealed the 
current ethical taboo against intentionally destroying a fetus or embryo for the pursuit of 
science. "' From this point onv ard, proponents of fetal lissue transplant and later 
embryonic stem cell research echoed his complaint that anti-abortion arguments 
" 
I letcbcr, John. C, "ETI-IICS: How Abortion Politics Stitles Science, " The IVashingron Post, 5 Feb. 
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illogically and caustically immobilize beneficial research. Although the current stem 
cell debate does not typically focus on AS cells, this early association with fetal 
transplant tissue would accompany AS cells as scientists further explored their potential 
during the early and mid-1 990s. 
Stem Cell Growth: 1990-1997 
In February 1990, stem cells took on a personal side when parents of seventeen 
year old Anissa Ayala decided to have a second child to save Anissa. Despite the four to 
one odds against producing a matching donor, her parents decided to do this so that 
Anissa's doctors could use the stem cell rich umbilical cord blood from their newborn to 
treat Anissa's leukemia. According to an Associated Press article, the event raised the 
ire of many bioethicists including law and medicine professor Alexander Morgan 
Capron of the University of Southern California who stated, "one of the fundamental 
prcccpts of ethics is that each person is an cnd in himself or herself, and is never to be 
used solely as a means to another person's ends without the agrccmcnt of thc person 
being used. " For a second time, AS cells became associated with the ethical debate 
regarding the rights of the newborn and unborn. This article was thc first to mention 
umbilical cord blood as a resource for AS cells, a fact that v:ould become extremely 
important throughout Ihe rest ol' Ihe 1990s. In August ol' that year The Hrravhirtgion Post 
printed a similar personal interest story about a four year old boy v ith incurable 
leukemia who doctors successfully treated v ith his infant sister's umbilical cord blood. '" 
' 
"Baby Is Conceived To Save Dau bter, " The ivew York Tmres, 17 Feb. I990: A10. 
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Using infants' stem cell-filled cord blood to treat their ailing siblings remains in use as 
one of the major successes of stem cell treatments. These personal stories served to 
increase public familiarity and interest with stem cell and their treatment potential, and 
raised ethical questions of whether people should create embryos for the purpose of 
helping others. Some articles however remained free of ethical discussions. A July 
1990 article in The New York Times entitled "Source of Hair Regeneration Found at an 
Unexpected Site" lauded new research in hair growth that demonstrated that small 
clusters of stem cells beneath the scalp were responsible for hair growth. " This 
discovery prompted scientists to rethink some of their earlier notions of tissue 
development because they had previously believed that hair grev strictly from thc bulb 
at lhe base of the hair follicle. Within the non-scientific understanding, this required 
people to expand their conception of the term 'stem cells. " Now, people learned, stem 
cells exisled not only within the bone marrow but also in the scalp and perhaps other 
places. 
Perhaps one of the most important events in Ihe history of AS cells occurred in 
September 1990 when an unidenlilled four year old underwent the first attempt at 
treating an immunological discase v ith gene therapy. This moment was noteworthy 1'or 
stem cells not because they provided the source of the genetically modified cells but 
because it marked their failure lo live up to expectations. Despite years of hope that 
stem cells could one day transport new genetic material, scientists had not yet adequately 
figured out how to isolate and manipulate them. Thus v hen The ffroshingron Post 
"nn ier, tsatalie, "Source of Hair Regeneration Found at an Unexpected Site, " The tven Vttrk Tuner, 3 
. I u I y 1 990: C 3. 
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declared in their headline "First Gene-Therapy Patient Opens Door to Treating 4, 000 
Inherited Diseases" they noted that stem cells had failed to provide the answers which 
doctors had hoped for during the 1980s. This failure marked a low point in the history 
of AS cell research. During the next two years, articles spoke only of bone marrow 
treatments and the use of placental and cord blood. Although articles in both magazines 
and newspapers mentioned stem cells, they did not report on them with the expectancy, 
personal interest, or detail that had been prevalent in previous reports. 
Then in 1994, stem cells and other biotechnology received an enormous influx of 
attention from the media. To begin this important year for biotechnology, Time' s 
January 17"' cover article, entitled 'Thc Genetic Revolution, " discussed the wide range 
of issues that could arise from new genetic treatments and research. ' Within the broad 39 
topic of genetics, Ihe article discussed genetic screening, gcnc therapy, and the ethical 
issues of what to do with the tvealth of genetic technology sure to come. Stem cells 
come into the article when Ihe authors discuss the first gene therapy treatment from 
1990. Since the recipients received only white blood cells that eventually die, Ihey 
would have to receive regular new infusions. In order to solve this issue, Dr. Michael 
Blaesc of the National Institutes of Health isolated stem cells from his patient and 
grafted in the genetic alteration. He then injected the modified stem cells into one of the 
original gene therapy pioneers and watched the candidate thrive, Although his team 40 
had not published the ftndings at the lime, Blaese accomplished something that scientists 
'" 
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had pursued for years. His use of stem cells began a year of important gains in medicine 
and science as well as significant political involvement with the reinvigorated stem cell 
topic. 
In February 1994, the NIH took one of the first steps in governmental 
intervention of bioteclmology by creating the Human Embryo Research Panel. This 
panel, consisting of a varied field of researchers, ethicists, and medical doctors, 
assembled in response to the end of the federal funding ban on embryonic research 
established in the early 1980s, and to provide government supervision for the ongoing 
research within the biotech field. Although this panel's formation made for a 
momentous event, only The washington Post mentioned it. In Boyce Rensberger's 
article "NII-I Panel Looks at L'thics, Standards I'or Human Embryo Research. " he noted 
testimony from scientists complaining that "in the absence of NIH's traditional peer 
reviev process, v'hich scientists must pass to get government funding -- human embryo 
research has become dominated by a decidedly inferior brand of science. '" Along v, ith -41 
federal funding, they presumed, came federal oversight of the science. The panel faced 
ethical questions about in vitro fertilization, gene therapy. and the use ol discarded 
human embryos for rcscarch. Although they had not yet isolated human embryonic stem 
cells, thc article shov:s scientists pleading for national funding and oversight that would 
raise American science to the preeminence it held in other areas of research. This I'oray 
of federal interest. in human embryonic rcscarch ended later that year v:hen President Dill 
Clinton stopped the NIH from providing funds. Interestingly, thc four major news 
" Resenberger. Boyce, "~ iH Panel i. ooks at Ethics, Standards for Human Emhrro Research, " The 
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sources missed this story completely. Why only one source noticed the formation of the 
panel and all four sources missed this significant series of events cannot be fully 
understood, especially since the events provided an interesting prelude to a debate that 
rages at the front of the current stem cell debate. 
Most of the other important stem cell news reported between 1994 and 1996 
consisted of stories similar to those earlier that decade. One medical issue that became 
increasingly important during this time dealt with saving placental and umbilical cord 
blood. In August 1994, The 8'ashington Post published "The Littlest Donor; Umbilical 
Cord Blood ls a Nev. Source of Marrow, " and discussed how the more immature stem 
cells found in umbilical cord blood could treat bone marrow diseases. Although the 
science itself was not new, the arlicle discusses the new notion of storing cord blood for 
the purpose of creating a national cord blood bank system. In 1996, Atetvsvreek wrote an 
article on lhe option of saving and storing a newborn's cord blood in case thc child 
developed some immunological disorder later in life. ' From this interest arose several as
companies thai specialized in the refrigeration of cord blood, and although thc process 
never reached the popularity they hoped, several companies still specialize in preserving 
cord blood. '1 he only other medically signiftcant news during this time period came in 
January 1996 when researcher Tao Chcng and David Scadden of the Nev Fngland 
Deaconess Hospilal in Boston announced in Science a new and simpler method for the 
isolation of bone marrovv stem cells. This progress increased stem cell yield to one in 
Colborn, Don, "The Littlest Donor; Umbilical Cord Blood Is a tstew Source of Marrow, " The 
lt ushington Post, 2 Aug. 1994 Zl0. 
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five of the blood cells separated rather than one in filly or one hundred. Clearly this 
discovery would provide significant assistance to those studying bone marrow stem cells 
in the future. 
Once again, major news sources missed the significant political advances 
regarding stem cells during the mid 1990s. In 1995, President Clinton issued an 
Executive Order to create the National Bioethics Advisory Commission. Although the 
commission would eventually become defunct, it was intended to evaluate the issue of 
federal funding for embryonic research as well as private sector research. When the 
creation of Dolly the sheep became public in 1997, President Clinton encouraged the 
NBAC "to undertake a thorough review of the legal and ethical issues associated with 
the use of this technology. " ' In 1996, the newly seated Republican majority began 
annual bans on public funding for any research using human embryos not just research 
requiring the destruction of an embryo. From this point, the political parties began to 
take sides within the embryonic and stem cell research debates. Again, why the 
newspapers ignored these significant political events remains unexplained. Perhaps they 
ignored the topics because embryonic research had not yct produced any signilicant 
scientific or medical achievements that the reading public would consider interesting. 
Regardless, they would correct their misstcps regarding the early stages of the political 
debate when science provided a momentous achievement with thc creation of Dolly. 
lan Wilmut and Keith Campbell of the Roslind Inslitute in Scotland created thc 
first clone from an adult sheep mammary cell in July of 1996. Betv, een . Iuly and late 
" Clinton, Bill in "Cioning lnmiun iieinpsi Report rind Recommendunons of tiie Vadonai Bioethics 
tdi icor& Ciimimssiun, " (Rockvillc, MD: National Bioethics Advisory Commission, . lone 1997)h 
February 1997, when the team made the results public, they cloned nine lambs from 
adult cells and forever changed biotechnology's prominence within the news and 
attention of popular culture. Undersmndably major news sources across the globe 
quickly seized on the topic with a deluge of articles covering all aspects of the story, 
Not only did every story report the scientific details of the process, but they also 
discussed the ethical and political impact that such a discovery would surely have. "The 
real question, of course, " as Newsweek reporter Sharon Begley put it, "was, wherever the 
lamb went, was Mary sure to follow?*' The ability to clone humans, once thought 
impossible by mainstream science, became, in the matter of a fcw days, a distinct 
possibility if not probability in the minds of everyone. This spark from the scientific 
community. ignited a large public discussion on how society should employ this new 
technology and its forthcoming progeny. This conversation took place within the pages 
of newspapers and magazines, thc halls of government, the hearings of ethics boards, 
and the normal work place. Although the debate over embryonic stem cells had not yct 
come in force, the publicity and discussion of cloning set in place many of the issues that 
would constitute the heart ol' the stem cell debate. 
While most nev's attention focused on the cloning si. ory, a fcw articles followed 
the course of stem cells during 1997 albeit they mostly occurred in connection with 
clonin&n In July 1997 stem cells made news in their own right when scientists 
announced they had maiiaged to influence bone marrov' stem cells to reproduce within 
thc lab. However, as The Vere York Times reported, as the cells divided they became 
"Begley, Sharon et al. , "Little Lamh, Who Made Thee, ' Wcaatvec(r. 10 Mar. 1997, 129, (ir 52-58. on p. 
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more developed and lost their plasticity. The inability to reproduce in the lab has 
remained the main problem with using AS cells, and stands as one of the major 
arguments against pursuing treatments from AS cells. Political and ethical discussion 
dominated the rest of the significant stem cell news. In June, The Washington Post 
reported that ethics boards in both the United States the European Union had come to a 
decision on the future of human cloning. Both boards determined that cloning with the 
purpose of producing an adult clone should be prohibited. Interestingly they also both 
agreed to allow cloning for the purpose of research as long as researchers never 
implanted the embryo in a uterus. With this approval, scientists could continue to create 
and destroy embryos for the purpose of science as long as lhe&r used no federal money 
for the destruction of embryos. 'l hc article mentions stem cells as one of thc promising 
new sciences that would come from I'ulure v:ork v'ith these non-implanted embryos. 
With this ethical clearance, James Thomson and the other teams attempting to isolate 
embryonic stem cells could bring their research efforts to fruition. 
The 1990s saw an explosion of grov th first in bone marrow and umbilical cord 
stem cells and second in cloning and embryonic research. Although reporters did not 
give much attention to the possibility ol ES cells, they did mention them as possibilities 
of v herc biotechnology might go next. Most likely, reporters did not fully understand 
exactly what an embryonic stem cell was. During l 996 and 1997, scientilic teams had 
begun to theorize about and search for LS cells but they had no promise of actually 
" Riordan, Teresa, "Patents; A Doctor Finds a Way to induce Rare Bone Marrow Cells to Reproduce 
Themselves in the Laboratory, " The tuew York Tones, 7 July 1997. D2. 
"Herman, Robin, "European Bioethics Panel Denounces Human Cloning. " The tfoshingron Post, 10 June 
1997: Z19. 
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isolating them. Instead, most ethicists, politicians, and laypersons focused on the 
multiple issues of cloning and embryonic research. Significantly, the discussion of these 
arguments set foundations for the multifaceted debate over embryonic stem cells that 
would soon ensue. 
Stem Cell Divide: 1998-2000 
The four years between 1998 and 2001 would prove to become the crucial years 
for the stem cell debate. Within this period the New York Times referred to the term 
"stem cell" in an astonishing 664 articles. Newsweek, who had used the term only eight 
times between 1980 and 1997, used "stem cell" in sixty-seven articles. Clearly the age 
of stem cells had arrived. During these four years political parties would become 
polarized on the issues, states would create bans on research, debate over ethics would 
spread from institutional boards and journals to the I Jnited States Congress, and 
scientists would race to keep up with the rapidly expanding firestorm they had ignited. 
I Jntil November 1998, no one could have predicted the unfurling of events over 
the next four years. Throughout 1998, stem cells remained buried within articles about 
cloning. In most cases, reporters continued to mention stem cells as a useful and 
possible byproduct of increased embryonic research. In February, The New York Tintes 
printed an editorial by bioethicist John A. Robertson ol' the llniversity of Texas in which 
he noted that to ignore embryonic research could prevent nev. treatments such as ES cell 
and fetal tissue transplants. " Although some stories noted the possibility of FS cells, 
few gave any explanation. All this cloudiness ended quickly in November. I'rom 
Rohcrtaon, . lohn A. , "Dchatc on Human Clonin I nores Some Rcnclits. " The ruete York Time). , 3 l'ch. 
199S' A22 
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November 6'" to the end of the year, The New York Times and The FVashingron Post 
produced nearly thirty articles dealing with the newly discovered ES cells. Interestingly 
though, most of the articles did not focus on the science that had led to such a creation. 
Both papers exhausted explanations of the new science and even the potential medical 
benefits within the first two or three days after Science printed Thomson's article. 
Reporters filled the gap with articles discussing a combination of politics and 
ethics. As early as November 7'", The New York Times printed an article entitled "A Ban 
on Cells That Could Heal. "' This small article from the editorial desk argued that 
Congress should abolish the ban on federal funding of embryonic research because the 
"gains arc potentially enormous and the ethical problems appear minimal. "' This 
understatement highlights the initial surprise that scientists and ES cell research 
proponents experienced in the early debate. Many ol' ihe proponents could not 
understand v'hy the pro-life lobby would lind using frozen embryos ethically 
problematic. They quickly discovered that opponents such as the National Right to Life 
Committee and the American Family Association not only decried the destruction of 
implanted embryos, but also resented thc destruction ol an embryo for any purpose. 
Avvare of their ncw albatross, FS cell proponents quickly began to argue lor federal 
funding for research on stem cells already derived lrom embryos. Soon thc NIH 
requested to hear from lawyers on whether the Congressional ban included ES cells 
because 1hey were technically not embryos. On November 10, 7'he Ale»~ Yiirk Times m 
'A Ban on Cells '1hal. Could Heal, " The We» Vori TImes, 7 is1ov. 1998: A14. 
'A Ban, ' p. Ala 
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printed an article explaining the complexities of the Congressional ban. The last 
significant article during this initial rush came from The Washington Post on December 
3 . Rick Weiss' article stated that scientists had once again appeared before the Senate 
to testify as to the necessity of lifting the federal funding ban. As long as the bans 
existed, they claimed, the United States could not become the world leader in ES cell 
research. Furthermore, Weiss claimed that scientists and ethicists believed Congress had 
enacted the ban to prohibit the creation of an adult clone. As previously noted, Congress 
had actually created the ban to prevent federal funding of research that destroyed an 
embryo not created one. Regardless, the senate hearings would have no effect, and the 
ban remained in place. 
While scientists failed to have the ban lifted, they won the other point of 
conienlion. In January 1999 the Department of Health and Human Services handed 
dovvn its decision that the NIH could provide funding for research performed on stem 
cells. Although the NIII would not create guidelines for getting grants until later that 
year, researchers rejoiced that they could now get federal funding as long as they did not 
create or destroy embryos. With the possibility of this ncw source of funding, FS cell 
proponents hoped for significant advances for treatment of spinal cord injuries, 
Parkinson's disease, Alzheimer's disease, and morc, but 1999 would witness almost no 
medical or scientific advances. 
Wade. Nicholas. "Primordial Cells I'uel Debate on Ethics, " Thc Vew York Times, 10 Nov. l998: Fl. 
" Weiss, Rick, "Ban on 'Stem Cell' Testing Reviewed; Ai Scnaic Hearin, Advocates Offer Fvidence of 
Rcsearctt's Medical Promise, ' The lfashingirrn Prtsi, 3 Dcc. 1 998 F 1. 
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Instead, following the January announcement, politicians began a year of 
defining the debate. Even before Health and Human Services had come to a decision, 
The IVashi ngron Post published an editorial by researcher Daniel Perry entitled "Promise 
(and Pitfalls) of Research. " Perry argued that the possible benefits of ES cell research 
outweighed the ethical concerns some people held. He claimed that the thirty years of 
abortion debate had so debilitated the United States Congress that it could not reach a 
reasonable and fair decision. Furthermore, he suggested, "elected officials with little or 
no scientific uaining are neither well prepared nor generally comfortable with parsing 
issues of cell biology. "" Unreasonable as it may be, Perry preferred that ignorant 
legislators not waste their time trying to figurc out minute ethical details and instead 
trust that scientists would make good moral decisions. Neither the legislative nor 
executive branches would prove so obliging. Instead they both spenl much of 1999 
lislening to testimony from rcscarchers and convening ethics panels. One such panel did 
provide some hope for researchers in April when it announced that researchers could use 
federal funds to purchase LS cells already destroyed by privately funded labs. Despite 
opposition from the House Pro-Life Caucus and the National Cont'erence of Catholic 
Bishops, the panel agrccd with Secretary of llealth and Human Services Donna Sbalala 
that such I'unding did not violate the Congressional ban. ' In 1999 the United States 
government took control of lhe FS cell topic, and consequently slowed the advance that 
many proponents had expected. 
Perry. Daniel, "Promise(and Pitfalls) of Research, " The WurhinXrr n Roar, 7. lan. l999. A25. 
5 ' Perry. "Promise, " p. A2th 
' Wade, Nicholas, "Panel DraAs Rules For I lumen bhnbryo Study, " tire Vere Yr&rk Ttrrter, 9 Apr. l999: 
A20. 
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One of the few scientific advances made during 1999 came from the unexpected 
source of AS cells. According to a May article from The 8'ashingtorr Post, scientists 
discovered a technique using rats to turn bone marrow into liver cells. This significant 57 
event suggested the possibility that some AS cells could form cell types and tissue other 
than those they normally form. For the first time, this raised the question: "if AS cells 
could be coaxed into becoming other types of tissue then could AS cells supplant the 
ethically contested ES cells?" In April 2000, Rick Weiss of The Washington Post wrote 
an in depth article on the further potential of such "cell alchemy. "' In his article, Weiss 
commented that scientists had already discovered how to manipulate neuronal cells lo 
morph into other types of valuable cells, and that in April 1999 a team from Baltimore 
reported being able lo turn bone marrow stem cells into bone, muscle, cartilage, 
ligament, tendon. and fat tissue. A similar article from The Aretp York Times in August 
of 2000 reported I hat scientists had managed to take human bone marrow stem cells and 
turn them into neuron cells. Clearly this incredible discovery held great promise for 
treatment of diseases such as Alzheimer's and Parkinson's which are both caused by the 
deplelion of neuron cells. Dcspitc these signilicant gains in the laboratory. AS cells 
remained a secondary aspect within the ongoing stem cell debate. 
One argument currently put forth by several opponents of ES cell research. such 
as conservative bioelhicists, reporters, and scientists, holds that major news media have 
' 
'Bone Marrow Cells Can Become Liver Tissue. Animal Siudiea Show, ' The JVarhington Post. 14 May 
1999: A19. 
'" Weisa, Rtck, "In Cell 'Alchemy, ' an Alternative to Fmbtyo Studies. " The li uahington Post, 24 Apr. 
2000: A I I. 
Kolata, Otna, "Scientists I ind New Method OI Producing Nerve Cells, " The New York Ttmer, 15 Au . 
2000: A10. 
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ignored the advances made in AS cells, and indisputably news media have reported more 
thoroughly on the ES cell debate. In hundreds of articles printed between 1999 and 
2000, only a few dealt with the possibilities posed by advances in AS cells. However, 
the news media cannot be held completely responsible for ES cells overshadowing AS 
cells. The attention given to ES cells has been fueled by intense political and ethical 
interest, and so the news media often find stories on ES cells more appealing to their 
readership. Most of the stories in both newspapers and magazines that provided 
examples of successful treatment options involved AS cells. For ES cell opponents to 
suggest that popular media excludes developments on AS cells is not entirely correct 
because, as demonstrated here, they have reported their successes. Still, news sources 
could improve their coverage of the overall topic and more clearly present the 
weaknesses and strengths of both. By equalizing coverage, news media could give the 
public a more extcnsivc familiarity with the debate and its multiple medical, ethical, and 
political complexities. 
Perhaps the most compelling reason to increase reporting on AS cells should be 
thai since 1998, ES cell research has been crippled by debate and managed to yield few 
notable advances. The remainder of 1999 and most of 2000 progressed much like the 
early part of 1999. Despite a large pool ol'articles on FS cells, fev' of them brought 
significant new information. As the government trudged on in its attempt to regulate 
I'ederal funding and research progressed v iihout any marked discoveries, newspapers 
and magazines focused on the continuing moral issues of ES cells. During 2000, similar 
pleads for Congress to lift thc federal funding ban continued, and opinion pieces 
readdressed the necessity of working through the slue of ethical issues. All the while, 
articles continued to report on the successes of AS cells. One Reuters' article in 
February demonstrated the continued confusion among the press as to the difference 
between ES and AS cells. In the article, the author began by reporting of scientists at the 
University of Florida using stem cells to treat diabetes in mice. The article then 
proceeded to state that "stem cells have been the subject of much interest since their 
potential was discovered just over a year ago. " The problem was that for the rest of the »60 
article the author discussed the scientists' use of AS not ES cells as his or her other 
commentary led the reader to believe. During thc article the author claimed that such 
advances should fuel future stem cell research but without actually saying which stem 
cell research. Although most articles on AS cells provide more information, this type of 
confusion over stem cell types is one of the problems that opponents of ES cell research 
decry. 
In the area of biotechnology business, reporters wrote with better clarity. Private 
biotechnology companies arose during the late-19g0s but did not reach their height until 
after the economic and scientific growth of the mid-1990s. With the advent of ES cells 
and their expcctcd revolution of medicine, investors immediately became interested in 
biotech of all types. Geron, the company that had funded James Thomson and other 
embryonic research pioneers. quickly found stout competition from numerous startup 
biotech companies during 1999 and 2000. Because thc United States could not. provide 
funding for the creation or destruction of embryos. research relied heavily on the money 
'" 
"Scientists Say Cell Treatment Can Reverse Diabetes in Mice, ' The iyem &'ark Times, 29 I'eb. 2000: 
A19. 
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provided by biotechnology companies planning to purchase the patent once the 
researchers had made the discovery. Evidence of the fast growth of these companies 
appeared in the business pages of both newspapers and magazines during 1999 and 
2000. Needless to say, the subsequent delays and absence of patentable scientific results 
from embryonic research deflated the biotech bubble. After 2001 investor excitement 
over biotechnology has waned but by no means disappeared. One of the inherent aspects 
of biotechnology, as scientists regularly remind, is that significant and profitable 
progress often moves slowly. Since 2000, the market has eliminated several biotech 
companies and adjusted to the slower pace of the industry. 
As 2000 progressed, the media's attention turned to the upcoming election. 
While stem cells had become a hotly. debated topic, they had not reached the point that 
newspapers brought them into campaign articles. Despite the press' apparent lack of 
interest, the candidates did have separate opinions on where they believed stem cell 
research should progress. The campaign helped to del inc where the parties stood 
regarding bioethical issues, because the candidates offered their. and subscqucntly those 
of many in their parties, vieivs on the direction of stem cell research. Vice-President Al 
Gore supported research in all areas of technology, cspccially stem cells, and said he 
would allow fcdcrally funded laboratories to create embryos with the intent to create 
new stem cell lines. Many in the Democratic Party, with the backing of many scientists, 
largely supported this method and claimed embryological stem cells held greater 
promise for treatment, but would require thc creation of new lines to maintain an 
adequate supply of stem cells. Meanwhile, Texas Governor George Bush claimed, to thc 
44 
delight of the pro-life lobby, he would not support technology "that involves the 
destruction of live human embryos. " ' Most, but not all, Republicans rallied behind 
Bush and claimed that, as with abortion, the destruction of a human embryo represented 
the destruction of human life. 
The years between 1998 and 2000 witnessed the government's and the public's 
reaction to ES cells. Many proponents of ES cell research, such as the American 
Medical Association, claim that the government's slow reaction to the events has cost 
science and patients the many promises that researchers initially promised. While this 
may be the case, the delays were not without warrant. To dive headlong into an area 
surrounded with such enormous moral questions could have mired research beyond 
v herc it is today. The events of this time period had two important outcomes, one good, 
one bad. First, the combination of' Ihe government's engulfing and the press' reporting 
assured that the public and the political process would provide guidance on the future of 
stem cell research. While not all people may scc this as a good thing, in a democratic 
society, the citizens rather than a small group of individuals should decide issues ol such 
magnitude. Second, the issue fell along the pro-life/pro-choice divide. While this fact 
served in the stemming of the research tide, it has since fallen short ol' 1'ully 
comprehending the aspects ol' Ihe debate. The issues of embryonic stem cells dcscrvc an 
accounting of thc ethical issues in its own right. From 2001 to the present. ethicists, 
politicians. and the public have attempted to do this, and have had mixed results. 
" 
"Candidate. Bush opposed cmhryo stem cell rcscarch, " (CNN. corn, 9 Aug. 2001 h 
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Stem Cell Decision; 2001 to the Present 
In August 2001, stem cells received more attention from the press than in any 
month before or after. The month stood as the zenith in a year that had been filled with 
news on stem cells. On January 26'", only a few days after President Bush took office, 
Rick Weiss of The Washington Post reported that "Fetal Cell Research Funds Are at 
Risk; Scientists Fear Curbs Over Abortion. " As his title indicated, ES cell proponents 
now feared that the new conservative president would attempt to cut the federal funding 
for ES cell research that had been established under President Clinton's administration. 
Although such a possibility existed, the President would first have to overcome differing 
opinions within his own administration. In June, Ceci Connolly and Rick Weiss 
coauthored a IItrtshington Post article that noted the division over stem cells that existed 
within his cabinet. According to the article, Secretary of Health and Human Services 
Tomniy Thompson preferred to allow federal research on stem cells, and stated, 
"hopefully wc'll come up with a decision that's going to allow for the continuation of 
research, which is very important, and at the same time take into consideration the legal 
and lhe ethical questions that have to be considered. " Congress likewise found the „63 
issues complex. In July, The Nettr York Times released a series of stories that covered 
hov; various factions within Congress favored different approaches to the issue. Among 
headlines such as "61 Senators Call for Stem Cell Rcscarch' and 'Conscrvativcs 
' Weiss Rick, "Fetal Cell Research 1'unds Arc at Risk; Scienl. isis Fear Curbs O~er Abortion. " The 
kpashrngron Post, 26 Jan. 2001 A3. 
"Connolly, Ceci and Rick Weiss. "Stem Cell Research Divides Administration; Thompson Expresses 
Optimism That a Comprotnise Will Bc Reached Soon. " The lrrrrhmgrnn Purl, 12 June 2001. AS. 
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Pressure Bush In Cell Debate, " the articles addressed how finding a compromise could 
prove precarious for President Bush. 
To add to this precariousness, ES cells had finally shown signs of scientific 
progress. In July 2001, The New York Times' article, "Researcher Sees Early Success 
Using a 2nd Type of Stem Cell, " claimed that researcher John Gearhart of Johns 
Hopkins University had managed to make damaged nerves in mice move again by 
injecting ES cells. While this treatment did not use ES cells to regenerate cells, it 
showed that ES cells could reinvigorate damaged cells. Then on April 27, both 
newspapers published articles on three studies using ES cells that shovved hope for 
diabetes and Alzheimer's treatments. In one study. scientists had shown that old rats 
injected with human fetal brain cells gained improved memories. This would be useful 
to patients with Alzheimer's who experience gradually dccrcasing brain function. In the 
second study. scientists used chemicals to stimulate ES cells to grow into pancreatic 
cells that could produce insulin thai diabetics lack. In thc third, scientists cloned rat 
embryos and proved that the ES cells created from the clones malched the donor's DNA 
exactly. Scientisls and FS cell proponents finally managed to produce useful and eye- , 66 
catching results not a moment too soon. While these findings showed no sign ot 
producing a treatment, they did provide kindling for thc debate raging in American 
politics. 
Wade, Nicholas, "Researcher Sees Farly Success Using a 2nd 1ypc of Stem Cell, ' The Juew York Tmres, 
26 July 2001: A14. 
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On August 10, 2001, President Bush announced that aller much deliberation he 
had decided to disallow the creation of new stem cell lines and allow use of only the 
sixty four already existing and in compliance with certain specifications. Bush 
explained he could not cross a "fundamental moral line by providing taxpayer funding 
that would sanction or encourage further destruction of human embryos that have at least 
the potential for life. " 
Bush's decision satisfied almost no one, as Washington Post reporter Michael 
Ruane quickly pointed out in his August 11th article, "Stem Cell Decision Only Adds To 
Debate; Many Oppose Bush Plan; Others Say It's Too Limited. " In article after article, 
newspapers and magazines addressed what the announcement meant, and noted the wide 
disagreement. Most of thc articles discussed the fact that researchers believed the 
limitation would make stem cell lines dillicult to obtain and conscqucntly slow research. 
Other articles, noted that the President's attempt at compromise had created a renev'ed 
interest in ethical questions and a new zea) among supporters and opponents. Some 
August articles did suggest that good could come from Bush's decision. On August 18', 
The rVew York Times printed an article entitled 'Officials Say Bush's New Stem Cell 
Policv May Streamline the Research Process. " The article suggested that since Bush's 
decision had scrapped the strict guidelines imposed by the NIH under the Clinlon 
administralion, scientists might have an easier time getting funding. 'I'hc renewed 
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attention encouraged Time to publish a cover story simply titled "Stem Cells. " The 
August 20'" article named the top stem cell scientists and for the first time proadded an in 
depth history of ES cell research since Thomson's 1998 isolation. An editorial from 
The New York Times printed on the same day entitled, "The Genius of George W. Bush, " 
claimed that while Bush's decision had not satisfied either pro-life or ES cell research 
supporters, it had been a political success for him. By reaching a compromise, Bush 70 
managed to set himself apart from the intense political battles that had ensued and would 
continue over stem cells. 
Discussion of Bush's decision continued with high volume through the cnd of the 
year. While the events of September 11'h moved political attention from the topic, the 
press continued to cover the repercussions into 2002. However, as Ihe country became 
increasingly embroiled in its War on Terrorism, stem cells cxpcrienced a trough in the 
news. On November 28" . President Bush issued and Fxecutive Order to create Thc 
Presidenl's Council on Bioethics. This board, headed by Leon Kass of the LJniversity ol' 
Chicago, would look into mruiy issues regarding the wide range of topics within 
bioelhics. While reporters continued to rcport on researchers' calls for more access lo 
stem cells and the ethical issues received renewed coverage. news sources published few 
scientific or political events during 2002. Onc of these few significant events occurred 
in March when two preliminary studies conducted in Florida and Scolland suggested that 
AS cells may not prove as flexible as previous studies had shov n. According to The 
washington Post's Justin Gillis, the nev studies stated that the earlier demonstrations of 
"I. emonick, IViichacl D, "Stem Cells: America*s Best. " time, 20 Aug. 2001, 158, ': 54-55. 
"Rich, Frank, "The Bienius of Bcorgc W. Bush, '* The iutnr fork 'limes, 18 Aug. 2001: A I5. 
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AS cell plasticity may have resulted from unpredictable reactions with other types of 
cells. ' Although Gillis does admit that the results required more scrutiny, those who 
complain that the media gives preference to ES cell research could note the title, 
"Questions Raised on Stem Cells; Adult Cells Found Less Useful Than Embryonic 
Ones, " as an example of media bias. In fact, if such a bias does exist, 2002 could have 
been the beginning. During this lull, few articles fully addressed the AS cell topic. 
Instead, news focused on smaller details such as who supported ES cells and who did 
not. 
Throughout the later history of stem cells, ethics became a topic to fall back on 
during droughts of medical or political news. Many of the articles combed over the 
ethical issues without actually adding any new perspectives. As stem cell interest 
waned, articles began relating stem cells to cloning as they had before 1998. By 
December 2002. the debate had been reduced Io contests over words. As The Sett York 
I'i mes' Nicholas Wade noted in his article, Leon Kass of The President's Council on 
Bioethics had determined that the new term "therapeutic cloning" invented by Stanford 
rcscarchcrs to dcscribc thc creation of an embryo for the purpose of using its stem cells 
was too euphemistic. Although the term would become adopted, Kass objected thai 
Ihe name did not I'ully express the fact thai the process still rcquircd thc creation of a 
clone. Because scientists could derive stem cells without implanting an embryo, they 
argued that Iherapcutic cloning was not cloning because scientists would ncvcr implant 
' Gillis, Justin, "Questions Raised on Stem Cells; Adult Cells I ound Less Useful Than Embryonic Ones, " 
The IVnshhtsuvn Posh la Mar. 2002: A3. 
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the resulting embryo. As arguments became increasingly nebulous and complicated, 
both stem cell news and the debate needed something less abstract to rejuvenate it. 
In 2003 it received just that from both politics and medicine. In Bush's January 
State of the Union Address, he mentioned the importance of stem cells and cloning. 
Although the media paid little attention to his statement, Congress did. In early 2003, 
members in both Houses produced multiple cloning bills. David Weldon (R-FL) and 
Bart Stupak (D-MI) offered the first and the most prominent bill (HR 534) in January 
2003. This bill sought to prevent cloning of embryonic cells for any purpose including 
stem cell research derived from embryonic destruction. The other prominent House bill 
(HR 801), sponsored by Jim Greenwood (R-PA), would have outlawed the creation of 
embryonic clones only for the purpose of reproduction, but would have allowed 
development of stem cells for the purpose of experimentation. The Senate produced 73 
several similar bills. Sam 13rownback (R-KS) and Mary Landrieu's (D-LA) bill (S- 
1989) made similar allowances to those in the Weldon-Stupak bill. These bills sought to 
disallow the creation of clone embryos with the intent to destroy them for their contents. 
The Brownback-Landrieu bill did support the use of other nondestructive cloning for 
stem cells and tissue. Senate bills that coincided with the Greenwood bill, Specter- 
Harkin (S. 1893) and Feinstein-Kennedy (S. 1758) likewise supported cloning of 
embryos to provide research material. 74 
i'arcy, Mary Agnes. "House Considers Cloning Ban, 
" (C-span. org, 24 Feb. 2003). 
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News media covered this legislative activity from a distance. On January 30 
The 8'ashington Post's Rick Weiss wrote an article that explained the basic issues within 
the debate as well as the supporters of various bills. ' Weiss, whom opponents of ES 
cell research claim reports with a distinct pro-ES cell bias, made no mention of 
Democratic support from Landrieu or Stupak, but did note the Republican support of the 
bills in favor of increased ES cell and cloning research. The New York Times took a 
different approach to the ongoing political debate, and on January 24 published an 
editorial from Leon Kass insisting that Congress needed to separate the stem cell issue 
from cloning in their pursuit of legislation for both. ' Both sides of thc stem cell debate 
favored such an action. Since fev, people support cloning, FS cell opponents believed 
that by splitting the debate they could illegalize cloning in general and put an cnd to thc 
possibility of therapeutic cloning. Proponents realized that as long as ES cells remained 
attached to cloning that they v ould not get evaluated on their own merit. Despite the 
support for splitting them no nev, legislalion arrived. The Weldon-Stupak bill passed the 
1 louse on February 28, 2003, but Democratic leadership managed to pigeonhole lhe 
Brownback-l, andrieu bill and it never came to vote. The bills closely resembled many 
of Bush's 2001 statutes, but dealt morc specifically with the production of cloned 
umbrae'os I'or lhe purpose of research. Had the bill passed, not only would the 
government refuse funds to embryo destroying research bul also v'ould have I'orbidden 
the private sector from cloning embryos for any purpose. 
' Wciss, Rick, "t3cbate About Cloning Returns to Congress: Senate Considers Ban Affecting I lumen 
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As the war in Iraq became more politically important, ES cell and cloning news 
dropped from politics and returned to ethical discussions similar to those that had 
occurred during 2002. Unlike 2002, the newspapers printed a few stories about the 
progress of AS cells in treating various diseases. In a March article titled, "Bone 
Marrow Harbors Cells That Can Fix the Pancreas, " The New York Times reported recent 
discoveries by doctors that suggested bone marrow cells could "repair the liver, the heart 
and now the pancreas*'. ' The article also pointed out the difference between AS and ES 
cells, but noted that scientists believed they needed to continue research on ES cells. 
Another article in April reported that doctors could now perform stem cell transplants 
from donor*s corneas that would allow recipients to grow valuable epithelium tissue and 
defeat blindness from burns or rare diseases. During this time, no articles reported 7S 
treatment successes using LS cells. While some FS cell opponents would suggesl. Ihat 
this was indicative of FS cells failure to produce any treatments, lhe fact that the 
government had slowed ES cell treatments needs to bc taken into account. 
Despite their impediments of lack of federal funding and a limited number of ES 
cell lines, rcscarchers continued to plod on and produce treatments as quickly as 
possible. A September article from I'Ite Neve York Tintes reported that "Researchers on 
Stem Cells Are Making Do, and I loping. " Since Bush's decision in 2001, most »79 
researchers had continued in both their research and their efforts to encourage thc Bush 
Wade, Nicholas, "Bone Marrow 1 latbots Cells That Can Fix the Pancreas, " The iuew Vork 7'imes, 15 
Mar. 2003: A12. 
" Kinkead, Owen, "Stern Cell Ttansplants Offer New Hope in Some Cases of Blindness, " The, Vew Vr&rk 
Times, IS Apr. 2003: F7. 
"Santora, Matc, 'Researchers on Stem Cells Are Making Do, and Hoping, " The New Vork Ttmen 17 Sep. 
2003. Bs. 
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administration and Congress that their work would need more time and funding before it 
could produce its anticipated results. Currently, the NIH supports increased scientific 
efforts in both AS and ES research, and it claims that neither one should not be 
considered more important than the other. Extremely bright and talented researchers 
currently work on both veins, and as research continues, it becomes more apparent that 
each kind may prove more suited to its own set of cures. Even so, as long as political 
and ethical contention exists over ES cell research, scientists will have the burden of 
simultaneously researching and validating their research to the public. The thing 
researchers probably need more now than anything is a renevved interest in ES cell 
science and treatments from the public. Researchers in the llnited States got a surge of 
help from their South Korean colleagues when they announced the first successful 
isolation of stem cells from a cloned embryo in February 2004. Although this reignited 
the editorial pages and increased article output, it has not yet managed to take root in the 
American conscious. The year 2004, however. is still relatively young and rumors have 
already begun about new Congressional legislation on cloning and stem cells. ES cell 
research has spent most of its grownup life under a conservative administration. With 
thc possibility of a ncw administration in carly 2005, thc remainder of 2004 will 
hopefully provide an opportunity to ivork out some of the complex moral issues at play. 
54 
CONCLUSION: A STEM CELL FUTURE 
As a result of the vast interest and significance of stem cells, an almost 
inexhaustible supply of newspaper and magazine articles exists on the topic. Electronic 
and televised news, sources from which most people now get their news, hold an even 
greater supply of information on stem cells, The type of news available on the internet, 
as in all things, varies greatly based on the specific agendas of the page. Most of the 
major news sources on the internet such as cnn. corn, foxnews. corn, etc. contain 
information similar to what has been presented in this paper. Other news and 
information on the subject varies greatly in accuracy and truth. Since ES cell research 
and cloning have become such debated topics, an almost endless amount of information, 
both true and untrue, exist on the internet. As such, searching through even a small 
portion ol' the total rcsourccs of news and discussion would be extremely difficult and 
far beyond the capacity of this paper and most likely any paper. instead, this paper 
discusses the major moments in the history of stem cells as reported in major news 
sources. It is by no means a comprehensive review of stem cells in the media as it pays 
little attention to thc location of thc stories within the pages of the nev spapers and 
magazines. Since the early 1990s, stem cell have been on front pages and cover stories 
as vvell as buried wiihin the later pages. As such, this paper serves as only a general 
indicator of how the popular press has covered the major medical, ethical. and political 
issues within the stem cell debate. News sources typically cover thcsc three sides 
because they rcalizc that the general public's attention focuses on ihe aspecis of the 
debate that affect or have the potential io affect them the most. Based on observations of 
55 
news coverage from the past decade and a half, the media foremost discuss possible 
medical applications, followed by the political issues and then ethical considerations 
involved. 
Stem cell coverage began in the early 1980s with articles solely mentioning the 
potential medical advances of a new and relatively unknown aspect within anatomy and 
physiology. Scientists focused intensely on adult stem cells found within the bone 
marrow, and although these cells proved difficult to isolate, scientists continued research 
efforts with the hope that stem cells could one day transport regenerative gene therapy. 
Despite the fact that AS cells ncvcr fulfilled their initial expectations, scientists spent thc 
latter parts of the 1980s expanding their understanding and developing techniques for 
isolation that would prove extremely valuable to the important advances made during thc 
1990s. In the early part of the 1990s, news sources added a personal side to the medical 
treatments with several stories on the umbilical cord blood from infants being used io 
treat the otherwise incurable leukemia of their older siblings. 
As the 1990s progressed, scientists continued their research on bone marrow 
transplants and the isolation of adult stem cells. Then in 1998 with ihe advent of 
embryonic stem cells and their pluripotency, scientists sought to discover the ability ol 
both L'S and AS cells to form completely new tissues. Work on ihcsc thcorics has 
proceeded to today wilhin laboratory and animal testing, but despite successes with some 
lab and animal trials, no revolutionary medical treatments have come I'rom these studies. 
Most articles since 1998 proclaim the creation of radical ncix treatments for diseases 
such as Parkinson' s, Diabetes, and spinal cord injury as a result of continued and 
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research on ES cells. These treatments are typically listed as compelling reasons to 
expand and fund ES cell research. However, an equally common statement in news 
stories from doctors and researchers pursuing these treatments has been that possible 
treatments are ten to fifteen years away. Some people feel, as expressed in cartoonist 
Mike Luckovich's cartoon "Stem Cell Research" (Figure 1), that the promises of 
revolutionary new treatments have fallen short. Regardless, news sources have been rife 
with ES cell content during 2004 as a result of South Korean scientists' creation of 
cloned ES cells and the consequent renewed interest in the future of American stem cell 
and cloning sciences. 
 
Figure 1: "Stem Cell Research" 
By permission ol' Mike Luckovich and Creators Syndicate, Inc. 
Copyright, 2003. 
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While medical advances have been at the heart of stem cells since newspapers 
first reported on them, politics remained almost completely absent from early discussion 
of stem cells. Although stem cells had been in the news since the early 1980s, reporters 
presented few connections between stem cell research and politics until John Fletcher's 
article "ETHICS: How Abortion Politics Stifles Science. " While Fletcher had no idea 
about embryonic stem cells, he made the argument that reporters, bioethicists, and 
eventually politicians continue to make today. They claim that politics surrounding the 
abortion debate have wrongly carried over and interfered with the progress of science 
and medicine. The modem political debate over stem cells however did not have its 
basis until Thomson isolated ES cells. Since the 2000 election, stem cells and cloning 
have become a major but not decisive point ol'political contention and promises io 
remain one in the near 1'uturc. The political realm has attempted to guide and evaluate 
stem cell research vAth thc National Institutes of Health guidelines on allov;able 
research, President Bush's declaration of limitations on federal funding, and creation of 
The President's Council on Bioethics, have yel to create a federal standard on research. 
Currently, all sides would agree that thc most important political issue involves thc 
creation of federal legislation to deal with the many issues generated by stem cell 
research. Surprisingly, the IJniied States has become one of the lasi. developed nations 
to come to a decision on thc future of stem cells. While several states have already 
decided to ban or fund research, the 1'uture path of stem cell research in the I Jnited States 
will remain in limbo until the fcdcral government creates delinitive and encompassing 
legislation. 
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Necessary to the creation of such legislation will be the consideration of the 
ethical ramifications within the stem cell debate. News sources have related stem cells 
with ethical issues since scientists first planned to use them in genetic therapy, and, 
although the exact ethical questions have changed, the fundamental question about the 
limits of science remain. The creation of ES cells significantly elevated the intensity and 
complicated the moral debate surrounding stem cell use. One important result has been 
the ethical debate's shift out of the realm of institutional bioethicists and into a more 
open forum. While people involved in the sciences or President's Council continue to 
author the majority of editorials on stem cell and cloning topics, many of the transactions 
now take place on the editorial pages of popular media rather than within the walls of 
research institutions or bioethics mcctings. This venue shift combined with the 
increasing popularity of stem cells among the public has sharply influenced the topic 
within politics 
Throughout the history of stem cells in American news media. the three issues of 
medical advances, politics, and ethics have become inextricably linked. Nowadays, only 
a few articles fail to mention all three of these topics, and how they affect thc current 
status and I'uture of stem cells. Clearly, each of thc three has a significant effect on the 
other. As researchers appeal to the government for increased availability ol ES cells and 
funding, politicians must make decisions thai will represent the desires of their 
constituents. As the ethical debate bccomcs increasingly important to the public, their 
opinions will exert influence on their poli lical representatives. In the end, the future of 
stem cell research within thc United States will be determined by the decisions of 
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political figures. This has both positive and negative aspects, Hopefully, a legislative 
and political determination of stem cells' future means that the final decision will 
represent the will of the majority. As such, an informed public will prove critical in 
order to reach an educated and reasoned decision. So far, the press has clearly failed to 
present the multiple gains in the area of AS cell research, including the re-growth of 
muscle and heart tissue in some animals. For this, American news sources have a 
responsibility to provide complete coverage of advances on both adult and embryonic 
cells. 
Unfortunately, a political decision also means that the battle will be fought along 
the old pro-life/pro-choice lines. Not only do these arguments fail to comprehend the 
entire ethical argument about stem cells, but they also invigorate old feuds when more 
conciliatory methods should prevail. As in all things political, thc final decisions will 
come as a resuli. of wrangling over words, facts, and ideas. As a major factor of 
education and fact reporting in modem society, popular newspapers and magazines have 
a responsibility to provide clear explanations of all aspects of 0us wide and complex 
issue. As the understanding and manipulation of siem cells and cloning expand, the 
public must have the facts needed to make judgments that will not only provide society 
v;ith otherv;ise impossible cures, but also avoid frightening Brave A'ew lVovld visions of 
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